Adakveo Injection
Product Images NDC 0078-0883
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Adakveo (NDC 0078-0883). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel Ndc 0078-0883-61 Rx Only Adakveo® (crizanlizumab-tmca) Injection 100 mg/10 mL (10 mg/ml) For Intravenous Infusion After Dilution. 1 Single-dose Vial. Discard Unused Portion. Novartis (Seg101 02)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.